Form 4: HCA Healthcare Director, Nancy Ann Deparle, Reports Acquisition of Common Stock

Director Nancy Ann Deparle reports acquisition of 645 shares of HCA Healthcare common stock related to restricted share units.

Summary

• On April 29, 2025, Nancy Ann Deparle, a director of HCA Healthcare, Inc., acquired 645 shares of common stock.
• The acquisition was related to restricted share units attributable to an annual director equity award.
• These restricted share units will vest on the earlier of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date.
• Following the transaction, Deparle beneficially owns 21,401 shares of HCA Healthcare common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating a director's stock acquisition through an equity award, which is neither particularly positive nor negative.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted share units will vest on the sooner of the date of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common in publicly traded companies like HCA Healthcare.

Comparison to Industry Standards

• Director equity awards are a standard component of compensation packages in the healthcare industry, aligning director interests with shareholder value.
• Companies like Universal Health Services and Tenet Healthcare also utilize restricted stock units as part of their director compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with those of the shareholders.

Key Dates

Keywords

HCA Healthcare, Director, Stock Acquisition, Form 4, Beneficial Ownership, Restricted Share Units, Equity Award